1. Introduction
2. Country Outlook
2.1. Demographic Trend
2.2. Economic Scenario
2.3. Political Scenario
2.4. Stock Market Movement over the last year
2.5. Trade Dynamics
2.5.1. Import-Export
2.5.2. Major Global Trading Partners
3. Singapore Demographic Dividend Outlook
3.1. Total Fertility Rate in Singapore
3.2. Factors Affecting Fertility Rate in Singapore
3.3. Key Policies and Regulations
4. Technological Advancements
4.1. Market Size and Forecast
4.2. Investment Analysis
4.3. Government Initiatives
4.4. Number of People arriving for medical treatment per year
4.5. Number of tourists arriving for IVF treatment per year
5. World Bank and United Nations Outlook For Singapore Healthcare Sector
6. Singapore IVF Treatment Market By Product Type
6.1. Introduction
6.2. Reagents & Media
6.3. Instruments
6.3.1. Incubators
6.3.2. Centrifuge
6.3.3. Micromanipulator Systems
6.3.4. Cryosystems
6.3.5. Other Instruments
6.4. Accessories
7. Singapore IVF Treatment Market By Treatment Type
7.1. Introduction
7.2. Conventional IVF
7.3. ICSI (Intracytoplasmic Sperm Injection)
7.4. Donor Egg IVF
7.5. Frozen Embryo Transfer (FET)
7.6. Others
8. Singapore IVF Treatment Market By End User
8.1. Introduction
8.2. Fertility Clinics
8.3. Hospitals
8.4. Others
9. Analysis of Key Market Players
9.1. Virtus Health
9.2. Thomson Medical Pte. Ltd.
9.3. Esco Medical Pte. Ltd.
9.4. Raffles Medical Group Ltd.
9.5. IHH Healthcare
9.6. Sincere Healthcare Group Ltd.
9.7. Alpha International Women’s Specialist Pte Ltd
9.8. Monash IVF Group Ltd.
9.9. Foundation Women’s Centre and Foundation Children’s Centre Pte Ltd
9.10. Aspire Centre For Women & Fertility Pte. Ltd.
10. Singapore IVF Treatment Market Outlook
10.1. Market Size and Forecast
10.1.1. Short Term
10.1.2. Medium Term
10.1.3. Long-term
10.2. Cost Comparison of IVF Treatment in Singapore and Other Major Countries
10.3. Competitive Intelligence
10.4. Regulatory Framework
10.5. Total Cost of Ownership
11. Future Outlook
List of Tables
List of Figures